Cargando…
Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis
INTRODUCTION: Huntington’s disease (HD) is an autosomal dominant disorder caused by an expanded CAG repeat on the short arm of chromosome 4 resulting in cognitive decline, motor dysfunction, and death, typically occurring 15 to 20 years after the onset of motor symptoms. Neuropathologically, HD is c...
Autores principales: | Fink, Kyle D, Rossignol, Julien, Crane, Andrew T, Davis, Kendra K, Bombard, Matthew C, Bavar, Angela M, Clerc, Steven, Lowrance, Steven A, Song, Cheng, Lescaudron, Laurent, Dunbar, Gary L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854759/ https://www.ncbi.nlm.nih.gov/pubmed/24456799 http://dx.doi.org/10.1186/scrt341 |
Ejemplares similares
-
Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington’s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number
por: Rossignol, Julien, et al.
Publicado: (2015) -
Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014) -
Distinct Roles of Bcl-2 and Bcl-Xl in the Apoptosis of Human Bone
Marrow Mesenchymal Stem Cells during Differentiation
por: Oliver, Lisa, et al.
Publicado: (2011) -
Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease
por: Al-Gharaibeh, Abeer, et al.
Publicado: (2017) -
Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
por: Wyse, Robert D., et al.
Publicado: (2014)